Please wait while the formulary information is being retrieved.
RENVELA (SEVELAMER CARBONATE)
- Renal osteodystrophy with hyperphosphatemia
- Sevelamer Carbonate Tablet
- Sevelamer Carbonate Oral Powder Packet
- Renvela Tablet
- Renvela Oral Powder Packet
- By Indication
800 mg tablet
- 1 tablet (800 mg) by oral route 3 times per day with food
0.8 gram oral powder packet
- 1 packet (0.8 gram) mixed with 30 ml of water, stir and drink within 30 minutes, by oral route 3 times per day with meals
2.4 gram oral powder packet
- 1 packet (2.4 gram) mixed with 60 ml of water, stir and drink within 30 minutes, by oral route 3 times per day with meals
800 mg tablet
- 1 tablet (800 mg) by oral route 3 times per day with food
0.8 gram oral powder packet
- 1 packet (0.8 gram) mixed with 30 ml of water, stir and drink within 30 minutes, by oral route 3 times per day with meals
2.4 gram oral powder packet
- 1 packet (2.4 gram) mixed with 60 ml of water, stir and drink within 30 minutes, by oral route 3 times per day with meals
Renal osteodystrophy with hyperphosphatemia
- 1 packet (0.8 gram) mixed with 30 ml of water, stir and drink within 30 minutes, by oral route 3 times per day with meals
- 2 tablets (1,600 mg) by oral route 3 times per day with meals
- 2 packets (1.6 gram) mixed with 30 ml of water, stir and drink within 30 minutes, by oral route 3 times per day with meals
- 1 packet (2.4 gram) mixed with 60 ml of water, stir and drink within 30 minutes, by oral route 3 times per day with meals
- 1 tablet (800 mg) by oral route 3 times per day with food
- None
Contraindicated
- Curad Enema
- Disposable Enema
- Enema
- Enema Disposable
- Fleet Enema
- Fleet Enema Extra
- Fleet Pediatric
- K-phos No 2
- K-phos Original
- K-phos-neutral
- methenamine mand-sod biphos
- Oral Saline Laxative
- Osmoprep
- Phos-nak
- Phospha 250 Neutral
- Phosphate Laxative
- potassium & sodium phosphates
- potassium phosphate dibasic
- potassium phosphate, monobasic
- potassium&sodium monobas phos
- Preparation Cleansing
- Ready-to-use Enema
- sod phos mono-sod phos dibasic
- sod phos,di & mono-K phos mono
- sodium phosphate
- sodium phosphates
- Uroqid-acid No.2
Severe
Moderate
- Armour Thyroid
- Cellcept
- Cipro
- Cipro Xr
- ciprofloxacin
- ciprofloxacin (mixture)
- Cytomel
- Juxtapid
- levothyroxine
- Levoxyl
- liothyronine
- liotrix
- lomitapide
- mycophenolate mofetil
- mycophenolate sodium
- Myfortic
- Nature-throid
- Np Thyroid
- Synthroid
- thyroid (pork)
- Thyrolar-1
- Thyrolar-1/2
- Thyrolar-1/4
- Thyrolar-2
- Thyrolar-3
- Tirosint
- Unithroid
- Westhroid
- Wp Thyroid
- Gastrointestinal obstruction
Contraindicated
- Gastroparesis
- Severe constipation
Severe
Moderate
- Dysphagia
- Gastrointestinal hypomotility
- Gastrointestinal tract surgery
- Vitamin D deficiency
RENVELA (SEVELAMER CARBONATE)
- Renal osteodystrophy with hyperphosphatemia
- Peritonitis
- Acute abdominal pain
- Constipation
- Diarrhea
- Dyspepsia
- Flatulence
- Nausea
- Vomiting
More Frequent
Severe
Less Severe
- None
- Abdominal distension
- Anorexia
- Arthralgias
- Pruritus of skin
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Fecal impaction
- Gastrointestinal obstruction
- Hypersensitivity drug reaction
- Ileus
- Intestinal perforation
Less Severe
- Dysphagia
- Skin rash
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
None
Sevelamer
- Severity Level:
2
- Additional Notes: Systemic absorption not likely to occur
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
Sevelamer
Not systemically absorbed by mother, infant exposure unlikely
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Unknown | Not known; no or inclusive data | Not systemically absorbed by mother, infant exposure unlikely |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
| Renal osteodystrophy with hyperphosphatemia | |
| N25.0 | Renal osteodystrophy |
| 0-9 | A-Z |
|---|---|
| N25.0 | Renal osteodystrophy |
Formulary Reference Tool